Cargando…
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program
Despite past extensive studies, the mechanisms underlying pulmonary fibrosis (PF) still remain poorly understood. Here, we demonstrated that lungs originating from different types of patients with PF, including coronavirus disease 2019, systemic sclerosis–associated interstitial lung disease, and id...
Autores principales: | Wang, Yi, Zhang, Lei, Wu, Guo-Rao, Zhou, Qing, Yue, Huihui, Rao, Li-Zong, Yuan, Ting, Mo, Biwen, Wang, Fa-Xi, Chen, Long-Min, Sun, Fei, Song, Jia, Xiong, Fei, Zhang, Shu, Yu, Qilin, Yang, Ping, Xu, Yongjian, Zhao, Jianping, Zhang, Huilan, Xiong, Weining, Wang, Cong-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775789/ https://www.ncbi.nlm.nih.gov/pubmed/33277324 http://dx.doi.org/10.1126/sciadv.abb6075 |
Ejemplares similares
-
MBD2 facilitates tumor metastasis by mitigating DDB2 expression
por: Zhang, Lei, et al.
Publicado: (2023) -
Blockade of Mbd2 by siRNA-loaded liposomes protects mice against OVA-induced allergic airway inflammation via repressing M2 macrophage production
por: Wu, Guo-Rao, et al.
Publicado: (2022) -
The methyl-CpG-binding domain 2 facilitates pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiation
por: Wang, Yi, et al.
Publicado: (2022) -
Blockade of JAK2 protects mice against hypoxia‐induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation
por: Zhang, Lei, et al.
Publicado: (2020) -
MBD2 acts as a repressor to maintain the homeostasis of the Th1 program in type 1 diabetes by regulating the STAT1-IFN-γ axis
por: Yue, Tiantian, et al.
Publicado: (2021)